GP1BA

glycoprotein Ib platelet subunit alpha, the group of CD molecules

Basic information

Region (hg38): 17:4932277-4935023

Previous symbols: [ "GP1B" ]

Links

ENSG00000185245NCBI:2811OMIM:606672HGNC:4439Uniprot:P07359AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Bernard-Soulier syndrome (Definitive), mode of inheritance: Semidominant
  • Bernard-Soulier syndrome (Supportive), mode of inheritance: AD
  • platelet-type von Willebrand disease (Supportive), mode of inheritance: AD
  • autosomal dominant macrothrombocytopenia (Supportive), mode of inheritance: AD
  • Bernard-Soulier syndrome, type A2, autosomal dominant (Strong), mode of inheritance: AD
  • platelet-type von Willebrand disease (Strong), mode of inheritance: AD
  • Bernard-Soulier syndrome (Strong), mode of inheritance: AR
  • Bernard-Soulier syndrome (Definitive), mode of inheritance: AR
  • platelet-type von Willebrand disease (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Bernard-Soulier syndrome, type A2; Bernard-Soulier syndrome, type A1; von Willebrand disease, platelet-typeAD/ARHematologic; PharmacogenomicPreventive measures (eg, in the case of surgery) and treatment of bleeding episodes can be beneficial; Specific medications (eg, certain anesthetics) that interfere with platelet function should be avoidedHematologic18116504; 14081293; 6019024; 6286015; 6798442; 6333901; 2308962; 2052556; 1901273; 1730088; 8384898; 9616133; 11222377; 14711733; 21173099; 22102188; 23014764

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GP1BA gene.

  • not provided (8 variants)
  • Bernard Soulier syndrome (5 variants)
  • Bernard-Soulier syndrome, type A2, autosomal dominant (4 variants)
  • Pseudo von Willebrand disease (3 variants)
  • Bernard-Soulier syndrome, type A1 (2 variants)
  • Thrombocytopenia;Abnormal bleeding (1 variants)
  • Macrothrombocytopenia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GP1BA gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
30
clinvar
3
clinvar
34
missense
6
clinvar
11
clinvar
68
clinvar
6
clinvar
2
clinvar
93
nonsense
2
clinvar
1
clinvar
1
clinvar
4
start loss
0
frameshift
7
clinvar
6
clinvar
1
clinvar
2
clinvar
16
inframe indel
1
clinvar
1
clinvar
3
clinvar
3
clinvar
1
clinvar
9
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
Total 16 19 74 41 7

Highest pathogenic variant AF is 0.000118

Variants in GP1BA

This is a list of pathogenic ClinVar variants found in the GP1BA region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-4932557-A-T Benign (May 12, 2021)1224607
17-4932600-T-C not specified Benign (May 05, 2021)255460
17-4932636-C-T Inborn genetic diseases Uncertain significance (Dec 16, 2022)2206245
17-4932662-T-G Bernard-Soulier syndrome, type A2, autosomal dominant Pathogenic (Aug 15, 2023)1677261
17-4932666-A-C not specified Uncertain significance (Jun 07, 2024)3339694
17-4932668-G-T Inborn genetic diseases Uncertain significance (Feb 16, 2023)2485926
17-4932696-T-A Bernard-Soulier syndrome, type A2, autosomal dominant • GP1BA-related disorder Uncertain significance (Jun 13, 2023)2572118
17-4932696-T-C Pseudo von Willebrand disease;Bernard Soulier syndrome;Bernard-Soulier syndrome, type A2, autosomal dominant not provided (-)585094
17-4932701-T-C Bernard Soulier syndrome Uncertain significance (-)1695379
17-4932702-G-A Bernard-Soulier syndrome, type A2, autosomal dominant Likely pathogenic (-)1684403
17-4932702-G-C Macrothrombocytopenia Likely pathogenic (Feb 01, 2019)627167
17-4932706-CA-C Bernard Soulier syndrome Pathogenic (Oct 04, 2020)523620
17-4932710-A-G not specified • Bernard-Soulier syndrome, type A2, autosomal dominant;Nonarteritic anterior ischemic optic neuropathy, susceptibility to;Pseudo von Willebrand disease;Bernard Soulier syndrome Benign/Likely benign (Apr 01, 2023)255462
17-4932741-C-T Bernard Soulier syndrome • Bernard-Soulier syndrome, type A2, autosomal dominant • Inborn genetic diseases Conflicting classifications of pathogenicity (Jan 31, 2024)1679418
17-4932742-G-A GP1BA-related disorder Likely benign (Feb 10, 2021)3055053
17-4932751-AAC-A Macrothrombocytopenia Pathogenic (Feb 01, 2019)627001
17-4932764-CTGAG-C Pathogenic (Mar 03, 2023)2736403
17-4932773-A-G Bernard-Soulier syndrome, type A2, autosomal dominant • GP1BA-related disorder Likely pathogenic (Aug 01, 2023)1676741
17-4932775-C-A Macrothrombocytopenia • not specified • GP1BA-related disorder Conflicting classifications of pathogenicity (Jul 27, 2023)627016
17-4932776-C-T Inborn genetic diseases Uncertain significance (Apr 05, 2023)2533544
17-4932780-T-C GP1BA-related disorder Uncertain significance (Feb 21, 2023)2630317
17-4932795-T-C Bernard-Soulier syndrome, type A2, autosomal dominant Uncertain significance (-)1684363
17-4932798-C-T GP1BA-related disorder Uncertain significance (Oct 12, 2022)2629339
17-4932804-T-G Macrothrombocytopenia Uncertain significance (Feb 01, 2019)627031
17-4932810-C-T not specified • Bernard Soulier syndrome • Bernard-Soulier syndrome, type A2, autosomal dominant Conflicting classifications of pathogenicity (Jul 16, 2024)1285165

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GP1BAprotein_codingprotein_codingENST00000329125 12734
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.003230.62012450501481246530.000594
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3033683521.050.00002084149
Missense in Polyphen6873.8150.92122941
Synonymous-0.8111781651.080.00001051501
Loss of Function0.46345.130.7792.67e-755

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004010.000400
Ashkenazi Jewish0.000.00
East Asian0.0005030.000445
Finnish0.0007900.000789
European (Non-Finnish)0.001050.000974
Middle Eastern0.0005030.000445
South Asian0.00009970.0000980
Other0.0006870.000495

dbNSFP

Source: dbNSFP

Function
FUNCTION: GP-Ib, a surface membrane protein of platelets, participates in the formation of platelet plugs by binding to the A1 domain of vWF, which is already bound to the subendothelium.;
Disease
DISEASE: Non-arteritic anterior ischemic optic neuropathy (NAION) [MIM:258660]: An ocular disease due to ischemic injury to the optic nerve. It usually affects the optic disk and leads to visual loss and optic disk swelling of a pallid nature. Visual loss is usually sudden, or over a few days at most and is usually permanent, with some recovery possibly occurring within the first weeks or months. Patients with small disks having smaller or non- existent cups have an anatomical predisposition for non-arteritic anterior ischemic optic neuropathy. As an ischemic episode evolves, the swelling compromises circulation, with a spiral of ischemia resulting in further neuronal damage. {ECO:0000269|PubMed:14711733}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Bernard-Soulier syndrome (BSS) [MIM:231200]: A coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, thrombocytopenia, and impaired prothrombin consumption. {ECO:0000269|PubMed:10089893, ECO:0000269|PubMed:1730088, ECO:0000269|PubMed:7690774, ECO:0000269|PubMed:7819107, ECO:0000269|PubMed:7873390, ECO:0000269|PubMed:9639514}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bernard-Soulier syndrome A2, autosomal dominant (BSSA2) [MIM:153670]: A coagulation disorder characterized by mild to moderate bleeding tendency, thrombocytopenia, and an increased mean platelet volume. Some individuals have no symptoms. Mild bleeding tendencies manifest as epistaxis, gingival bleeding, menorrhagia, easy bruising, or prolonged bleeding after dental surgery. {ECO:0000269|PubMed:11222377}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pseudo-von Willebrand disease (VWDP) [MIM:177820]: A bleeding disorder characterized by abnormally enhanced binding of von Willebrand factor by the platelet glycoprotein Ib (GP Ib) receptor complex. Hemostatic function is impaired due to the removal of VWF multimers from the circulation. {ECO:0000269|PubMed:14521605, ECO:0000269|PubMed:2052556, ECO:0000269|PubMed:8384898, ECO:0000269|PubMed:8486780}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Platelet activation - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;GP1b-IX-V activation signalling;Platelet Adhesion to exposed collagen;Platelet Aggregation (Plug Formation);Platelet activation, signaling and aggregation;Intrinsic Pathway of Fibrin Clot Formation;Hemostasis;Formation of Fibrin Clot (Clotting Cascade);Transcriptional regulation by RUNX1;Beta2 integrin cell surface interactions (Consensus)

Recessive Scores

pRec
0.550

Intolerance Scores

loftool
0.630
rvis_EVS
0.14
rvis_percentile_EVS
63.62

Haploinsufficiency Scores

pHI
0.109
hipred
N
hipred_score
0.327
ghis
0.412

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.883

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gp1ba
Phenotype
hematopoietic system phenotype; homeostasis/metabolism phenotype; cellular phenotype;

Gene ontology

Biological process
cell morphogenesis;cell adhesion;cell surface receptor signaling pathway;blood coagulation;blood coagulation, intrinsic pathway;platelet activation;regulation of blood coagulation;fibrinolysis;regulation of megakaryocyte differentiation;thrombin-activated receptor signaling pathway;platelet aggregation
Cellular component
extracellular space;plasma membrane;integral component of plasma membrane;cell surface;membrane;extracellular matrix;anchored component of external side of plasma membrane;extracellular exosome
Molecular function
protein binding;thrombin-activated receptor activity